News
-
When the work is personal: how a program associate builds resources for the rare disease community
Discover how Andra Stratton uses her personal and professional experiences to support the patient-led organizations improving the lives of people affected by rare disease.
-
CZ Biohub welcomes new university-nominated Investigators
-
Uncovering sarcoidosis: The rare disease impacting black women in the U.S.
Sarcoidosis is an inflammatory disease disproportionately impacting Black women in the U.S. But the patient advocacy community is coming together to improve diagnosis and treatment.
-
In the blood: How fatherhood shaped one scientist’s path
-
Trends in Genetics: decade of molecular cell atlases
-
Who's feeding the fish?<br/>The robot!
Biohub-built ‘ZAF’ automates zebrafish care in the lab
-
2 Stanford researchers are using AI to see more in the brain
Learn why Stanford Researchers Wah Chiu and Serena Yeung are using artificial intelligence to reveal the inner workings of neurons.
-
A popular at-home test detects most infectious Omicron cases, a study suggests.
-
Chan Zuckerberg Biohub announces $86 million in new funding to Investigators at Stanford, UCSF, and UC Berkeley for visionary early-stage research
Second cohort of CZ Biohub Investigators includes awardees from a broad range of disciplines, with fresh approaches to biological and medical problems
-
Listen: Discussing the Future of Science Technology with Neuroscientist Edward Boyden
Neuroscientist Edward Boyden, Mark Zuckerberg, and Priscilla Chan discuss the future of biomedical science, including imaging, technology development, and artificial intelligence.
-
Watch: Building Tools to Accelerate Science with Medscape’s Dr. Eric Topol
Mark Zuckerberg and Priscilla Chan discuss CZI’s work in science, including our 10-year vision to measure human biology in action with physician-scientist, author and editor Dr. Eric Topol.
-
Chan Zuckerberg Initiative Announces 10-Year Effort to Develop Science and Technologies to Measure Human Biology in Action
Dr. Priscilla Chan and Mark Zuckerberg announced that they are doubling down on their commitment to accelerating biomedical science and advancing human health